- Recommendation ID
- IPG641/1
- Question
Further research, ideally in the form of randomised controlled trials, on the safety and efficacy of prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia should report details of patient selection (including prostate size and the amount of median lobe enlargement), improvement in lower urinary tract symptoms in the short term and long term, re-intervention rates, and outcome measures of sexual function using established methods.
- Any explanatory notes
(if applicable) Current evidence on the safety and efficacy of prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia is limited in quantity and quality. Therefore, this procedure should only be used in the context of research.
Source guidance details
- Comes from guidance
- Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia
- Number
- IPG641
- Date issued
- January 2019
Other details
| Is this a recommendation for the use of a technology only in the context of research? | Yes |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/01/2019 |